Endosome, Lysosome, Peroxisome Marker Antibody Panel (Catalase, Caveolin1,... Reference: ARG30310 Endosome, Lysosome, Peroxisome Marker antibody; CD107a / LAMP1 antibody; CLTC / Clathrin heavy chain antibody; Caveolin 1 antibody; Catalase antibody
Bavunalimab Reference: HY-P99354 Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer.
Aselizumab Reference: HY-P99443 Aselizumab (HuDreg-55) is an humanized IgG4 mAb against L-selectin. However, L-selectin (CD62L) is a cell adhesion molecule expressed on circulating neutrophils. It regulates migrating cells to chemotaxis towards the site of injury. Aselizumab may be account for a high rate of infections and leucopenia after truma.
Lupartumab Reference: HY-P99718 Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980.
General Lymphocyte Marker Antibody Panel (CD3, CD14, CD16, CD19, CD56) Reference: ARG30313 General Lymphocyte Marker antibody; CD19 antibody; CD3 antibody; APC-conjugated CD14 antibody; PE-conjugated CD16 antibody; PerCP-conjugated CD56 / NCAM antibody
Tislelizumab Reference: HY-P99052 Tislelizumab, a monoclonal antibody with high binding affinity to the PD-1 receptor, minimizes Fcγ receptor binding on macrophages, thereby abrogating antibody-dependent phagocytosis, a mechanism of T cell clearance and potential resistance to anti-PD-1 research. Tislelizumab can be used for the research of advanced squamous non-small-cell lung cancer.
Chondrogenesis Marker Antibody Panel Reference: ARG30314 Chondrogenesis Marker antibody; CDKN2A / p16INK4a antibody; CD44 antibody; FOXC2 antibody; FOXC1 antibody
Valanafusp alfa Reference: HY-P99530 Valanafusp alfa (AGT-181) is a brain penetrating recombinant fusion protein of a chimeric monoclonal antibody against the human insulin receptor (HIR) and human iduronidase (IDUA). Valanafusp alfa can be used for the research of Mucopolysaccharidosis type I (MPS I) .
Polatuzumab Reference: HY-P99042 Polatuzumab is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b .